Biogen
The Latest
-
Samsung Group In Talks to Acquire U.S. Drug Producer Biogen
Biogen shares climbed 9.5% to end at $258.31 after the news. 
Biogen shares climbed 9.5% to end at $258.31 after the news. -
U.S. FDA Grants New Hope For Alzheimer Sufferers
More than 6 million Americans suffer from Alzheimer's disease. 
More than 6 million Americans suffer from Alzheimer's disease. -
Apple And Biogen To Investigate Ability Of Apple Watch To Detect Cognitive Health Decline
Apple and Biogen announced a new research study that seeks to develop cognitive health biomarkers using an iPhone and Apple Watch. 
Apple and Biogen announced a new research study that seeks to develop cognitive health biomarkers using an iPhone and Apple Watch. -
Biogen’s Stock Dived After Ending Trials For Alzheimer’s Disease Drug
Biogen posted its lowest share price in 14 years on after it terminated the trial for Alzheimer’s drug - "ENGAGE and EMERGE" trials. Biogen posted its lowest share price in 14 years on after it terminated the trial for Alzheimer’s drug - "ENGAGE and EMERGE" trials.
